By studying a clinically well-characterized cohort of patients with untreated newly diagnosed RA we have shown an association between circulating adiponectin and pro-inflammatory chemokines involved in the pathogenesis of RA as well as markers of inflammation, whereas leptin and resistin showed no such associations. Here, ADIPOQ is linked to rheumatoid arthritis.